InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,099.96
(
1.02%
)
US TECH 100
17,244.80
(
1.57%
)
Dow Jones
38,239.66
(
0.40%
)
Brent Oil
88.17
(
0.00%
)
Bitcoin
62,969.98
(
-1.21%
)
Post# of 6264
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

StockHighAlert-

Send PM Follow Ignore
Followers 129
Posts 23648
Boards Moderated 1
Alias Born 09/14/2016

StockHighAlert-

Re: None

Wednesday, 07/25/2018 2:42:59 PM

Wednesday, July 25, 2018 2:42:59 PM

Post# of 6264
$IVST News CLEVELAND, July 25, 2018 (GLOBE NEWSWIRE) -- Innovest Global Inc. (OTC Pink Current:IVST) (the "Company" or "Innovest"), reports that the patent application for the technology being developed by StemVax Therapeutics was approved. The patent is granted under the category of "Cancer Antigens", and related to the "treatment of cancer using vaccination therapy".
https://www.nasdaq.com/press-release/innovest-global-announces-patent-is-approved-for-stemvax-therapeutics-20180725-00640
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up